Electroacupuncture ameliorates cognitive impairment through inhibition of NF-κB-mediated neuronal cell apoptosis in cerebral ischemia-reperfusion injured rats

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1516-1522

  Feng, Xiaodong ^a   Yang, Shanli ^a   Liu, Jiao ^b   Huang, Jia ^a   Peng, Jun ^a   Lin, Jiumao ^a   Tao, Jing ^a   Chen, Lidian ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Baihui (DU20) and Shenting (DU24) acupoints; Cerebral ischemia reperfusion; Cognitive impairment; Electroacupuncture; Nuclear factor B pathway

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROACUPUNCTURE; LEARNING; MALE; MEMORY; MOLECULAR MECHANICS; NERVE CELL NECROSIS; NONHUMAN; RAT;

ACUPUNCTURE POINTS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN ISCHEMIA; CELL NUCLEUS; CEREBRAL INFARCTION; COGNITION DISORDERS; DOWN-REGULATION; ELECTROACUPUNCTURE; MALE; NEURONS; NF-KAPPA B; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84875984189     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1392     Document Type: Article

References (37)

1. Jokinen H, Kalska H, Mäntylä R, et al: Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 77: 28-33, 2006.
2. Lindeboom J and Weinstein H: Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. Eur J Pharmacol 490: 83-86, 2004.
3. Nyenhuis DL, Gorelick PB, Geenen EJ, et al: The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND). Clin Neuropsychol 18: 41-49, 2004.
4. Sachdev PS, Brodaty H, Valenzuela MJ, et al: The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 62: 912-919, 2004.
5. Mok V, Chang C, Wong A, et al: Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease. J Neuroimaging 15: 129-137, 2005.
6. Mok VC, Wong A, Lam WW, et al: Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry 75: 560-566, 2004.
7. Haring HP: Cognitive impairment after stroke. Curr Opin Neurol 15: 79-84, 2002.
8. Alvarez-Sabín J and Román GC: Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke 42 (Suppl 1): S40-S43, 2011.
9. Hachinski V and Munoz D: Vascular factors in cognitive impairment - where are we now? Ann NY Acad Sci 903: 1-5, 2000.
10. Tatemichi TK, Desmond DW, Stern Y, et al: Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 57: 202-207, 1994.
11. Desmond DW, Moroney JT, Paik MC, et al: Frequency and clinical determinants of dementia after ischemic stroke. Neurology 54: 1124-1131, 2000.
12. Mattson MP: Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1: 120-129, 2000.
13. Nakka VP, Gusain A, Mehta SL and Raghubir R: Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol 37: 7-38, 2008.
14. Broughton BR, Reutens DC and Sobey CG: Apoptotic mechanisms after cerebral ischemia. Stroke 40: e331-e339, 2009.
15. Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-of-death switch. Nat Rev Cancer 2: 647-656, 2002.
16. Borner C: Bcl-2 family members: integrators of survival and death. Biochim Biophys Acta 1644: 71-72, 2004.
17. Baeuerle PA and Baltimore D: NF-kappa B: ten years after. Cell 87: 13-20, 1996.
18. Taglialatela G, Robinson R and Perez-Polo JR: Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J Neurosci Res 47: 155-162, 1997.
19. Middleton G, Hamanoue M, Enokido Y, et al: Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol 148: 325-332, 2000.
20. Goodman Y and Mattson MP: Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J Neurochem 66: 869-872, 1996.
21. Mattson MP, Goodman Y, Luo H, et al: Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49: 681-697, 1997.
22. Grilli M, Pizzi M, Memo M and Spano P: Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274: 1383-1385, 1996.
23. Won SJ, Ko HW, Kim EY, et al: Nuclear factor kappa B-mediated kainite neurotoxicity in the rat and hamster hippocampus. Neuroscience 94: 83-91, 1999.
24. van der Kooij MA, Nijboer CH, Ohl F, et al: NF-kappaB inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats. Neurobiol Dis 38: 266-272, 2010.
25. Wu JN: A short history of acupuncture. J Altern Complement Med 2: 19-21, 1996.
26. Hu HH, Chung C, Liu TJ, et al: A randomized controlled trial on the treatment for acute partial ischemic stroke with acupuncture. Neuroepidemiology 12: 106-113, 1993.
27. Jansen G, Lundeberg T, Kjartansson J and Samuelson UE: Acupuncture and sensory neuropeptides increase cutaneous blood flow in rats. Neurosci Lett 97: 305-309, 1989.
28. Johansson K, Lindgren I, Widner H, et al: Can sensory stimulation improve the functional outcome in stroke patients? Neurology 43: 2189-2192, 1993.
29. Magnusson M, Johansson K and Johansson BB: Sensory stimulation promotes normalization of postural control after stroke. Stroke 25: 1176-1180, 1994.
30. Zhao L, Zhang H, Zheng Z, et al: Electroacupuncture on the head points for improving gnosia in patients with vascular dementia. J Tradit Chin Med 29: 29-34, 2009.
31. Chen LP, Wang FW, Zuo F, et al: Clinical research on comprehensive treatment of senile vascular dementia. J Tradit Chin Med 31: 178-181, 2011.
32. Chen AZ, Lin ZC, Lan L, et al: Electroacupuncture at the Quchi and Zusanli acu points exerts neuroprotective role in cerebral ischemia- reperfusion injured rats via activation of the PI3K/Akt pathway. Int J Mol Med 30: 791-796, 2012.
33. Zhang GZ, Liu AL and Zhou YB: Panax ginseng ginsenoside-Rg2 protects memory impairment via-anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol 115: 440-448, 2008.
34. Sarnico I, Lanzillotta A and Benarese M: NF-kappaB dimers in the regulation of neuronal survival. Int Rev Neurobiol 85: 351-362, 2009.
35. Freudenthal R, Romano A and Routtenberg A: Transcription factor NF-kappaB activation after in vivo perforant path LTP in the mouse hippocampus. Hippocampus 14: 677-683, 2004.
36. Zhang W, Potrovita I, Tarabin V, et al: Neuronal activation of NF-kB contributes to cell death in cerebral ischemia. J Cerebral Blood F Met 25: 30-34, 2005.
37. Kumar A, Takada Y, Boriek AM and Aggarwal BB: Nuclear factor-kB: its role in health and disease. J Mol Med (Berl) 82: 434-448, 2004.